All figures are reported in United States dollars ($) unless otherwise indicated
LAS VEGAS, NV / ACCESSWIRE / November 8, 2023 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNH) (“Planet 13” or the “Company“), a leading vertically-integrated multi-state cannabis company, today announced its financial results for the three-month period ended September 30, 2023. Planet 13’s financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”).
“I’m proud of our team’s ability to compete and maintain market share in a very competitive market. Based on available data, our dispensaries were responsible for almost one in every ten dollars of cannabis bought in Nevada. Our brands continued to perform well, being among the top selling in their respective categories. We look forward to bringing our retail experience and brands to Illinois and Florida in the coming months,” said Larry Scheffler, Co-CEO of Planet 13.
“This quarter, we took major steps towards executing the strategic goals we laid out at the start of the year and becoming a major player in Florida. We are also getting very close to opening our Illinois dispensary and completing the next phase of exciting new additions to the SuperStore. I’m very excited for 2024 when all our hard work starts to pay dividends,” commented Bob Groesbeck, Co-CEO of Planet 13.
Financial Highlights – Q3 – 2023
Operating Results
All comparisons below are to the quarter ended September 30, 2022, unless otherwise noted
Balance Sheet
All comparisons below are to December 31, 2022, unless otherwise noted
Q3 Highlights and Recent Developments
For a more comprehensive overview of these highlights and recent developments, please refer to Planet 13’s Management‘s Discussion and Analysis of the Financial Condition and Results of Operations for the Three and Nine Months Ended September 30, 2023 (the “MD&A“).
Results of Operations (Summary)
The following tables set forth consolidated statements of financial information for the three-month periods ending September 30, 2023, and September 30, 2022.
Financial Highlights
|
(Figures in millions
|
For the Three Months Ended | |||||||||||
|
and % change based
|
September 30, | September 30, | ||||||||||
|
on these figures)
|
2023 | 2022 | change | |||||||||
|
Total Revenue
|
$ | 24.79 | $ | 25.62 | -3 | % | ||||||
|
Gross Profit
|
$ | 11.07 | $ | 10.56 | 5 | % | ||||||
|
Gross Profit %
|
44.7 | % | 41.2 | % | 8 | % | ||||||
|
Net Loss Before Provision for Income Taxes
|
$ | (43.62 | ) | $ | (4.03 | ) | 981 | % | ||||
|
Net Loss
|
$ | (45.98 | ) | $ | (6.26 | ) | 635 | % | ||||
|
Adjusted EBITDA
|
$ | 0.23 | $ | 0.51 | -56 | % | ||||||
|
Adjusted EBITDA Margin %
|
0.9 | % | 2.0 | % | ||||||||
The Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, is available on the SEC’s website at www.sec.gov or at https://www.planet13holdings.com/investors/. The Company’s Management Discussion and Analysis for the period and the accompanying financial statements and notes are available under the Company’s profile on SEDAR and on its website at https://www.planet13holdings.com/investors/.
This news release is not in any way a substitute for reading those financial statements, including the notes to the financial statements.
Conference Call
Planet 13 will host a conference call on November 8, 2023 at 6:00 p.m. ET to discuss its third quarter financial results and provide investors with key business highlights, strategy, and outlook. The call will be chaired by Larry Scheffler, Co-CEO, and Dennis Logan, CFO.
CONFERENCE CALL DETAILS
Date: November 8, 2023 | Time: 6:00 p.m. EST
Participant Dial-in: Toll Free 877-545-0523 or International 973-528-0016. Access Code 754919
Replay Dial-in: Toll Free 877-481-4010 or International 919-882-2331
(Available for 2 weeks)
Reference Number: 49385
Listen to webcast: https://www.webcaster4.com/Webcast/Page/2477/49385
Non-GAAP Financial Measures
There are financial measures included in this press release that are not in accordance with GAAP and therefore may not be comparable to similarly titled measures and metrics presented by other publicly traded companies. These non-GAAP financial measures should be considered as supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. The Company includes EBITDA and Adjusted EBITDA because it believes certain investors use these measures and metrics as a means of assessing financial performance. EBITDA is calculated as net income (loss) before interest, taxes, depreciation and amortization and Adjusted EBITDA is calculated as EBITDA before share-based compensation, the change in fair value of warrants and one-time non-recurring expenses.
The following table presents a reconciliation of net income (loss) to Adjusted EBITDA for each of the periods presented:
|
Reconciliation of Non-GAAP Adjusted EBITDA
|
||||||||||||
|
(Figures in millions
|
For the Three Months Ended | |||||||||||
|
and % change based
|
September 30, | September 30, | ||||||||||
|
on these figures)
|
2023 | 2022 | change | |||||||||
|
|
||||||||||||
|
Net Income (Loss)
|
$ | (45.98 | ) | $ | (6.26 | ) | 635 | % | ||||
|
Add impact of:
|
||||||||||||
|
Interest income, net
|
$ | (0.28 | ) | $ | (0.12 | ) | 134 | % | ||||
|
Provision for income taxes
|
$ | 2.37 | $ | 2.22 | 6 | % | ||||||
|
Depreciation and amortization
|
$ | 1.97 | $ | 1.98 | -1 | % | ||||||
|
Depreciation included in cost of goods sold
|
$ | 0.99 | $ | 0.85 | 17 | % | ||||||
|
EBITDA
|
$ | (40.95 | ) | $ | (1.33 | ) | 2982 | % | ||||
|
Change in fair value of warrants
|
$ | – | $ | (0.20 | ) | -100 | % | |||||
|
Share-based compensation and related premiums
|
$ | 0.60 | $ | 2.04 | -70 | % | ||||||
|
Impairment loss
|
$ | 39.65 | $ | – | 0 | % | ||||||
|
Professional fees expensed related to NGW acquisition
|
$ | – | $ | – | 0 | % | ||||||
|
Professional fees expensed related to M&A activities
|
$ | 0.73 | $ | – | 0 | % | ||||||
|
Professional fees expensed related to SEC Domestic Issuer Form 10 filing and U.S Domestication from British Columbia to Nevada
|
$ | 0.19 | $ | – | 0 | % | ||||||
|
Adjusted EBITDA
|
$ | 0.23 | $ | 0.51 | -56 | % | ||||||
For more information on Planet 13, visit the investor website (www.planet13holdings.com/investors).
About Planet 13
Planet 13 (www.planet13holdings.com) is a vertically integrated cannabis company, with award-winning cultivation, production and dispensary operations in Las Vegas and in Orange County, California. Planet 13 also holds a medical marijuana treatment center license in Florida and a conditional Social-Equity Justice Involved dispensing license in the Chicago region of Illinois. Planet 13’s mission is to build a recognizable global brand known for world-class dispensary operations and a creator of innovative cannabis products. Licensed cannabis activity is legal in these states but remains illegal under U.S. federal law. Planet 13’s shares trade on the Canadian Securities Exchange (CSE) under the symbol PLTH and are quoted on the OTCQX under the symbol PLNH.
Cautionary Note Regarding Forward-Looking Information
This news release contains forward-looking information and forward-looking statements within the meaning of applicable securities laws. All statements, other than statements of historical fact, are forward-looking statements and are often, but not always, identified by phrases such as “plans”, “expects”, “proposed”, “may”, “could”, “would”, “intends”, “anticipates”, or “believes”, or variations of such words and phrases. In this news release, forward-looking statements relate to our strategic goals or future performance. Such forward-looking statements reflect what management of the Company believes, or believed at the time, to be reasonable assumptions and accordingly readers are cautioned not to place undue reliance upon such forward-looking statements and that actual results may vary from such forward-looking statements. These assumptions, risks and uncertainties which may cause actual results to differ include, among others: final regulatory and other approvals or consents needed to operate our business; fluctuations in general macroeconomic conditions; inflationary pressures; fluctuations in securities markets; expectations regarding the size of the cannabis market in the states in which we currently operate in or contemplate future operations and changing consumer habits in such states; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties including international conflict; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in the states in which we currently operate in or contemplate future operations; employee relations and other risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the U.S. Securities and Exchange Commission at www.sec.gov and on the Company’s issuer profile on SEDAR at www.sedar.com and in the Company’s periodic reports subsequently filed with the U.S. Securities and Exchange Commission and on SEDAR. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
For further inquiries, please contact:
LodeRock Advisors Inc., Planet 13 Investor Relations
mark.kuindersma@loderockadvisors.com
Robert Groesbeck or Larry Scheffler
Co-Chief Executive Officers
ir@planet13lasvegas.com
PLANET 13 HOLDINGS INC.
Interim Condensed Consolidated Balance Sheets
(Unaudited, In United States Dollars)
|
|
September 30, | December 31, | ||||||
|
|
2023 | 2022 | ||||||
|
ASSETS
|
||||||||
|
Current Assets:
|
||||||||
|
Cash
|
$ | 36,773,666 | $ | 52,356,914 | ||||
|
Accounts Receivable
|
1,220,209 | 1,326,795 | ||||||
|
Inventory
|
14,882,790 | 13,004,839 | ||||||
|
Prepaid Expenses and Other Current Assets
|
3,189,576 | 3,810,394 | ||||||
|
Total Current Assets
|
56,066,241 | 70,498,942 | ||||||
|
|
||||||||
|
Property and Equipment
|
68,259,905 | 71,466,051 | ||||||
|
Intangible Assets
|
31,451,215 | 69,288,007 | ||||||
|
Right of Use Assets – Operating
|
21,418,730 | 21,168,171 | ||||||
|
Long-term Deposits and Other Assets
|
832,853 | 862,545 | ||||||
|
Deferred Tax Asset
|
350,001 | 346,257 | ||||||
|
|
||||||||
|
TOTAL ASSETS
|
$ | 178,378,945 | $ | 233,629,973 | ||||
|
|
||||||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
|
LIABILITIES
|
||||||||
|
Current:
|
||||||||
|
Accounts Payable
|
$ | 2,709,208 | $ | 3,112,820 | ||||
|
Accrued Expenses
|
6,318,105 | 8,072,224 | ||||||
|
Income Taxes Payable
|
2,855,316 | 2,826,501 | ||||||
|
Notes Payable – Current Portion
|
884,000 | 884,000 | ||||||
|
Operating Lease Liabilities
|
580,142 | 479,161 | ||||||
|
Total Current Liabilities
|
13,346,771 | 15,374,706 | ||||||
|
|
||||||||
|
Long-Term Liabilities:
|
||||||||
|
Operating Lease Liabilities
|
26,663,701 | 25,833,071 | ||||||
|
Warranty Liability
|
– | 18,127 | ||||||
|
Other Long-term Liabilities
|
28,000 | 28,000 | ||||||
|
Deferred Tax Liability
|
1,480,695 | 1,487,204 | ||||||
|
Total Liabilities
|
41,519,167 | 42,741,108 | ||||||
|
|
||||||||
|
Commitments and Contingencies (refer to Note 16)
|
||||||||
|
|
||||||||
|
SHAREHOLDERS’ EQUITY
|
||||||||
|
Common Stock, no par value, 1,500,000,000 shares authorized, 222,247,854 issued and outstanding at September 30, 2023 and 220,470,061 at December 31, 2022
|
– | – | ||||||
|
Preferred Stock, no par value, 50,000,000 shares authorized, 0 issued and outstanding at September 30, 2023 and 0 at December 31, 2022
|
– | – | ||||||
|
Additional Paid-In Capital
|
314,628,834 | 312,023,359 | ||||||
|
Deficit
|
(177,769,056 | ) | (121,134,494 | ) | ||||
|
Total Shareholders’ Equity
|
136,859,778 | 190,888,865 | ||||||
|
|
||||||||
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
|
$ | 178,378,945 | $ | 233,629,973 | ||||
PLANET 13 HOLDINGS INC.
Interim Condensed Consolidated Statements of Operations and Comprehensive Loss
(Unaudited, In United States Dollars)
|
|
Three Months Ended | |||||||
|
|
September 30, | September 30, | ||||||
|
|
2023 | 2022 | ||||||
|
|
||||||||
|
Revenues, net of discounts
|
$ | 24,788,239 | $ | 25,623,217 | ||||
|
Cost of Goods Sold
|
(13,715,307 | ) | (15,064,315 | ) | ||||
|
Gross Profit
|
11,072,932 | 10,558,902 | ||||||
|
|
||||||||
|
Expenses:
|
||||||||
|
General and Administrative
|
11,340,678 | 11,309,955 | ||||||
|
Sales and Marketing
|
1,348,266 | 938,269 | ||||||
|
Lease Expense
|
767,860 | 723,955 | ||||||
|
Impairment Loss
|
39,649,448 | – | ||||||
|
Depreciation
|
1,965,607 | 1,978,403 | ||||||
|
Total Expenses
|
55,071,859 | 14,950,582 | ||||||
|
|
||||||||
|
Loss From Operations
|
(43,998,927 | ) | (4,391,680 | ) | ||||
|
|
||||||||
|
Other Income (Expense):
|
||||||||
|
Interest income, net
|
284,080 | 121,285 | ||||||
|
Foreign exchange gain (loss)
|
203 | (1,834 | ) | |||||
|
Change in fair value of warrant liability
|
– | 197,721 | ||||||
|
Other Income, net
|
98,861 | 41,487 | ||||||
|
Total Other Income
|
383,144 | 358,659 | ||||||
|
|
||||||||
|
Loss Before Provision for Income Taxes
|
(43,615,783 | ) | (4,033,021 | ) | ||||
|
|
||||||||
|
Provision For Income Taxes
|
||||||||
|
Current Tax Expense
|
(2,401,672 | ) | (2,238,493 | ) | ||||
|
Deferred Tax Recovery
|
36,465 | 15,989 | ||||||
|
|
(2,365,207 | ) | (2,222,504 | ) | ||||
|
|
||||||||
|
Net Loss and Comprehensive Loss
|
$ | (45,980,990 | ) | $ | (6,255,525 | ) | ||
|
|
||||||||
|
Loss per Share
|
||||||||
|
Basic and diluted loss per share
|
$ | (0.21 | ) | $ | (0.03 | ) | ||
|
|
||||||||
|
Weighted Average Number of Shares of Common Stock
|
||||||||
|
Basic and diluted
|
222,080,513 | 220,146,277 | ||||||
PLANET 13 HOLDINGS INC.
Interim Condensed Consolidated Statements of Cash Flows
(Unaudited, In United States Dollars)
|
|
Nine Months Ended | |||||||
|
|
September 30, | September 30, | ||||||
|
|
2023 | 2022 | ||||||
|
CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
|
||||||||
|
Net loss
|
$ | (56,634,562 | ) | $ | (10,356,121 | ) | ||
|
Adjustments for items not involving cash:
|
||||||||
|
Shared based compensation expense
|
1,926,595 | 6,154,338 | ||||||
|
Non-cash lease expense
|
3,840,610 | 3,364,265 | ||||||
|
Depreciation
|
9,184,602 | 8,156,634 | ||||||
|
Change in fair value of warrant liability
|
(18,127 | ) | (6,992,955 | ) | ||||
|
Loss on translation of warrant liability
|
– | (12,612 | ) | |||||
|
Loss on disposal of fixed assets
|
153 | 4,048 | ||||||
|
Deferred tax recovery
|
(6,509 | ) | – | |||||
|
Impairment of intangible assets
|
39,649,448 | – | ||||||
|
Proceeds from lease incentive
|
– | 1,100,000 | ||||||
|
Lease incentive amortization
|
(78,347 | ) | (238,469 | ) | ||||
|
|
(2,136,137 | ) | 1,179,127 | |||||
|
|
||||||||
|
Net Changes in Non-cash Working Capital Items
|
(3,256,283 | ) | 3,800,775 | |||||
|
Repayment of lease liabilities
|
(3,078,748 | ) | (2,645,471 | ) | ||||
|
Total Operating
|
(8,471,168 | ) | 2,334,432 | |||||
|
|
||||||||
|
FINANCING ACTIVITIES
|
||||||||
|
RSU withholding taxes paid in lieu of share issuance
|
(267,526 | ) | – | |||||
|
Proceeds from exercise of warrants and options
|
– | 97,980 | ||||||
|
Total Financing
|
(267,526 | ) | 97,980 | |||||
|
|
||||||||
|
INVESTING ACTIVITIES
|
||||||||
|
Purchase of property, plant and equipment
|
(6,043,180 | ) | (14,642,193 | ) | ||||
|
Proceeds from sales of fixed assets
|
64,876 | – | ||||||
|
Purchase of 51% interest in Planet 13 Illinois
|
(866,250 | ) | – | |||||
|
Net cash acquired through NGW acquisition
|
– | 1,493,922 | ||||||
|
Total Investing
|
(6,844,554 | ) | (13,148,271 | ) | ||||
|
|
||||||||
|
Effect of foreign exchange on cash
|
– | 3,103 | ||||||
|
|
||||||||
|
NET CHANGE IN CASH DURING THE PERIOD
|
(15,583,248 | ) | (10,712,756 | ) | ||||
|
|
||||||||
|
CASH
|
||||||||
|
Beginning of Period
|
52,356,914 | 61,588,843 | ||||||
|
|
||||||||
|
End of Period
|
$ | 36,773,666 | $ | 50,876,087 | ||||
SOURCE: Planet 13 Holdings
View source version on accesswire.com:
https://www.accesswire.com/801318/planet-13-announces-q3-2023-financial-results
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…